The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term ...

India has the highest burden of acute coronary syndrome and ST-elevation myocardial infarction (STEMI). The prevalence of CAD ...

Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) ...

Introduction ST-elevation myocardial infarction (STEMI ... All the patients have been included in the Galician Acute Myocardial Infarction Registry (Registro Gallego de Infarto Agudo de Miocardio ...

Introduction: Hypoxic liver injury (HLI) and Killip classification are poor prognostic factors in patients with ST-segment elevation myocardial infarction (STEMI). This study investigates the ...

The aim of this study was to assess whether this post-extrasystolic ST segment and T wave variation (PEST ... In patients with heart disease such as survivors of acute myocardial infarction, risk ...

Successful reperfusion following ST-segment elevation myocardial infarction ... However, only a minority of acute myocardial infarction (MI) patients present in such "ideal circumstances." ...

CKD staging: GFR categories. Kidney damage for ≥3 months. ACR categories. ACR=albumin-to-creatinine ratio. AKD=acute kidney disease. AKI=acute kidney injury. CKD=chronic kidney disease. eGFR=estimated ...

Serum Extracellular Vesicle-derived microRNA Profiles in Patients with ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Cardiovascular Innovations and ...

Given changes in patient characteristics and treatments over time, a contemporary risk model for patients with acute myocardial infarction (MI ... cardiogenic shock, and ST-segment elevation MI as the ...